Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis

Br J Haematol. 2010 Apr;149(1):152-5. doi: 10.1111/j.1365-2141.2009.08029.x. Epub 2009 Dec 8.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Transformation, Neoplastic / pathology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use*
  • Primary Myelofibrosis / pathology*
  • Recombinant Proteins
  • Remission Induction

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a